Industrial Biotechnology is currently worth €23 billion representing just 6% in sales of the overall worldwide chemicals market.
EFIB is now renowned by a global audience as the annual EU meeting place for business and policy on Industrial Biotech and the biobased economy.
At EFIB delegates are provided with an update on the status and outlook of biobased industries. EFIB is proud to foster engagement between policy makers, a broad range of stakeholders connected with the existing biobased value chain and seeks to reach out to, and include, new interlocutors.
For more information please visit the EFIB website.